| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2316 | 2019 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1076 | 2022 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 199 | 2021 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 141 | 2019 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 133 | 2022 |
| A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019 | 113 | 2019 |
| Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE … BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nat Genet 51 (3), 414-430, 2019 | 80 | 2019 |
| New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020 | 73 | 2020 |
| Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study H Saddiki, A Fayosse, E Cognat, S Sabia, S Engelborghs, D Wallon, ... PLoS medicine 17 (8), e1003289, 2020 | 63 | 2020 |
| Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ... Scientific reports 11 (1), 6448, 2021 | 58 | 2021 |
| Visual impairment in aging and cognitive decline: experience in a Memory Clinic M Marquié, M Castilla-Martí, S Valero, J Martínez, D Sánchez, ... Scientific reports 9 (1), 8698, 2019 | 53 | 2019 |
| Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers IE Jansen, SJ van der Lee, D Gomez-Fonseca, I De Rojas, MC Dalmasso, ... Acta neuropathologica 144 (5), 821-842, 2022 | 52 | 2022 |
| PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment L Kleineidam, V Chouraki, T Próchnicki, SJ van Der Lee, ... Acta neuropathologica 139, 1025-1044, 2020 | 50 | 2020 |
| Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI) I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ... Alzheimer's Research & Therapy 10, 1-12, 2018 | 46 | 2018 |
| Highly efficient production of GFP and its derivatives in insect cells for visual in vitro applications C Oker-Blom, A Orellana, K Keinanen FEBS letters 389 (3), 238-243, 1996 | 44 | 1996 |
| Novel triazolopyridylbenzamides as potent and selective p38α inhibitors J Aiguadé, C Balagué, I Carranco, F Caturla, M Domínguez, P Eastwood, ... Bioorganic & medicinal chemistry letters 22 (10), 3431-3436, 2012 | 41 | 2012 |
| Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes Application in fluoroimmunoassay ML Laukkanen, A Orellana, K Keinänen Journal of immunological methods 185 (1), 95-102, 1995 | 40 | 1995 |
| Use of proteoliposomes to generate phage antibodies against native AMPA receptor LK Jespersen, A Kuusinen, A Orellana, K Keinänen, J Engberg European Journal of Biochemistry 267 (5), 1382-1389, 2000 | 38 | 2000 |
| Covalent binding of urease on ammonium-selective potentiometric membranes MH Gil, AP Piedade, S Alegret, J Alonso, E Martinez-Fabregas, ... Biosensors and Bioelectronics 7 (9), 645-652, 1992 | 38 | 1992 |
| Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview C Delaby, CE Teunissen, K Blennow, D Alcolea, I Arisi, EB Amar, ... Alzheimer's & Dementia 18 (10), 1868-1879, 2022 | 36 | 2022 |
